PLEASE NOTE : This is a development system.
For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.
For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.
You are here : Home > PAD Profile : Mupirocin - Epistaxis
PAD Profile : Mupirocin - Epistaxis
Keywords :
nosebleed
Brand Names Include :
Bactroban
Traffic Light Status
Status 1 of 1.
Status :
Green (see narrative)
Important
Formulations :
- Nasal ointment
Important Information :
2% nasal ointment. Off-label use - 2nd line as per CKS epistaxis guidance.
Consider Naseptin unless unsuitable.
Trust Alignment :
Primary Care
ASPH
RSFT
SASH
SABP
Comments :
No comments returned.
Documents :
Guidelines
No guidelines returned.
Other Drugs
Other Indications
Additional Documents
No additional documents returned.
Committee Recommendations
Date
Committee Name
Narrative
05 February 2025
Surrey Heartlands Integrated Care System Area Prescribing Committee (APC)
The Surrey Heartlands Area Prescribing Committee agreed the traffic light status of this drug and indication as part of the Joint Formulary review.
Associated BNF Codes
12. Ear, Nose and Oropharynx
12.02.03. Nasal preparations for infection